OPY vs VRTX · P/E 13, rev $1.43B vs P/E 30, rev $12.00B
Oppenheimer Holdings Inc (OPY) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
OPY currently screens at market cap $1.15B and trailing P/E 12.8. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the OPY and VRTX stock pages for the full models.
Not investment advice.